The earnings call reflected a balanced view with strong growth in non-Medicare and hospice segments, supported by cost control measures, but offset by challenges in home health recertifications, hurricane impacts, and unresolved UnitedHealthcare negotiations.
Company Guidance
During Enhabit Home Health & Hospice's Q3 2024 earnings call, the company provided guidance indicating a revised outlook for the year due to several factors. For full-year 2024, the company now expects net service revenue between $1.31 billion and $1.46 billion and adjusted EBITDA ranging from $98 million to $102 million. This revision accounts for lower recertifications and the impact of Hurricanes Helene and Milton, which collectively are anticipated to reduce Q4 revenue and adjusted EBITDA by approximately $2 million. Despite these challenges, Enhabit highlighted positive trends, such as a 6.9% year-over-year increase in average daily hospice census and significant non-Medicare admissions growth of 20.1%. The company also noted strategic improvements, including a decline in Medicare visits per episode from 14.9 to 14.4, and the successful transition to centralized admissions, boosting referral conversion rates from 74.2% to 77.4%. Looking ahead, the company is focused on addressing underperforming branches and leveraging payor innovation contracts, which now account for 45% of non-Medicare visits, up from 19% the previous year.
Hospice Segment Growth
The hospice segment showed significant progress with a 6.9% year-over-year increase in average daily census for Q3 2024.
Improved Referral Conversion Rate
Referral conversion rate increased from 74.2% last year to 77.4% this year, due to centralized admission departments.
Non-Medicare Admissions Growth
Non-Medicare admissions grew 20.1% year-over-year, contributing to a total admissions growth of 5.6%.
Positive Cash Flow and Debt Reduction
Free cash flow generation of approximately $59 million year-to-date with a leverage ratio decrease to 4.8x and $10 million debt reduction.
Cost Control Initiatives
Cost per visit remained flat year-to-date with $3 million expected savings from restructuring care management and regional leadership.
---
Enhabit, Inc (EHAB) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
EHAB Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2024
$7.91
$7.92
+0.13%
Aug 06, 2024
$9.89
$8.50
-14.05%
May 08, 2024
$9.70
$8.29
-14.54%
Mar 06, 2024
$7.86
$9.60
+22.14%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Enhabit, Inc (EHAB) report earnings?
Enhabit, Inc (EHAB) is schdueled to report earning on Feb 12, 2025, TBA Not Confirmed.
What is Enhabit, Inc (EHAB) earnings time?
Enhabit, Inc (EHAB) earnings time is at Feb 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.